Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics

3.4(top 10%)

impact factor

461(top 50%)

papers

19.4K(top 10%)

citations

78(top 10%)

h-index

3.6(top 10%)

impact factor

543

all documents

20.1K

doc citations

127(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Estrogen Signaling: A Subtle Balance Between ER and ER	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	726
2	BLOOD-BRAIN BARRIER DRUG TARGETING: THE FUTURE OF BRAIN DRUG DEVELOPMENT	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	586
3	Cardiac Glycosides as Novel Cancer Therapeutic Agents	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2008	444
4	Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2004	401
5	Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	361
6	Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	356
7	STAT3 SIGNALING: Anticancer Strategies and Challenges	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2011	350
8	Cytochromes P450, Drugs, and Diseases	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	343
9	Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	315
10	Vasomotion: Mechanisms and Physiological Importance	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	288
11	Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2005	273
12	ROLE of MITOCHONDRIA in TOXIC OXIDATIVE STRESS	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2005	244
13	Resveratrol in Cardioprotection: A Therapeutic Promise of Alternative Medicine	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2006	222
14	MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTION	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2004	219
15	Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	218
16	TLRs: Differential Adapter Utilization by Toll-Like Receptors Mediates TLR-Specific Patterns of Gene Expression	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	204
17	Central Neural Mechanisms that Interrelate Sensory and Affective Dimensions of Pain	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	200
18	Optimizing Combination Chemotherapy by Controlling Drug Ratios	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	195
19	S-Glutathionylation: Indicator of Cell Stress and Regulator of the Unfolded Protein Response	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	191
20	MOLECULAR EFFECTS of lithium	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2004	189
21	Molecular Mechanisms of SERT in Platelets: Regulation of Plasma Serotonin Levels	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2010	186
22	Regulation of Receptors and Transporters by Ubiquitination: New Insights into Surprisingly Similar Mechanisms	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	185
23	Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2010	180
24	The Biology of Caveolae: Lessons from Caveolin Knockout Mice and Implications for Human Disease	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	178
25	S-Nitrosylation Signaling in Cell Biology	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	176
26	Diversity of the Neurotoxic Conus Peptides: A Model for Concerted Pharmacological Discovery	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	173
27	PLC- : A Shared Effector Protein in Ras-, Rho-, and G -Mediated Signaling	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	173
28	Histamine H3 Receptor Antagonists: Preclinical Promise for Treating Obesity and Cognitive Disorders	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2006	170
29	Small Interfering RNAs: A Revolutionary Tool for the Analysis of Gene Function and Gene Therapy	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	166
30	Addiction: Making the Connection Between Behavioral Changes and Neuronal Plasticity in Specific Pathways	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	164
31	Mechanism of Cancer Pain	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2010	152
32	Networking with AKAPs: Context-dependent Regulation of Anchored Enzymes	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2010	148
33	Advanced Drug Delivery Systems That Target The Vascular Endothelium	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2006	147
34	REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	146
35	REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	146
36	The Economics of Drug Abuse: a Quantitative Assessment of Drug Demand	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2005	145
37	COX-2 in Inflammation and Resolution	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2006	141
38	Unraveling the Story of NGF-mediated Sensitization of Nociceptive Sensory Neurons: ON or OFF the Trks?	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2007	131
39	The Choline Transporter Resurfaces: New Roles for Synaptic Vesicles?	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2004	130
40	Recent Advances in the Neurobiology of Schizophrenia	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	129
41	Biochemical Mechanisms of Cyclosporine Neurotoxicity	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2004	127
42	Inside Information: The Unique Features of Visceral Sensation	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2008	127
43	The TASK Family: Two-Pore Domain Background K+ Channels	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2003	126
44	NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICS	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2005	126
45	GAF Domains: Two-Billion-Year-Old Molecular Switches that Bind Cyclic Nucleotides	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2002	125
46	Pharmacology of Store-operated Calcium Channels	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2010	120
47	Sodium-Dependent Neurotransmitter TRANSPORTERS: OLIGOMERIZATION as a Determinant of Transporter Function and Trafficking	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2004	119
48	Targeting Cancer Stem Cells with Phytochemicals	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2008	119
49	Animal Models and Brain Circuits in Drug Addiction	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2006	117
50	The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) Reveals the Need for Better Understanding of Selenium Biology	Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics	2009	116

Scientometrics

Overviews

Citing Bodies

Molecular Interventions: Pharmacological Perspectives From Biology, Chemistry and Genomics

Top Articles